drugset / Trial / NCT01507597

The Effect of GLP-1 on the Inhibition of Glucagon Secretion

NCT01507597 ↗

RandomizedCrossoverSingle-blindBasic science

Summary

Diabetes(both types) are recognized by high levels of glucagon in the circulation. Glucagon is known to increase blood glucose, and might therefore contribute to the respective diseases. Under some circumstances the gut hormone GLP-1 inhibits the glucagon secretion. The investigators aim to identify the impact of GLP-1 on the glucagon secretion, at increasing blood glucose levels in healthy subjects, in patients with type 2 diabetes, and in patients with type 1 diabetes. The investigators think that the effect of GLP-1 on the glucagon secretion might be dependent of blood glucose levels.

Timeline

Start
2011-12
Primary completion
2013-08
Completion
2013-08

Drugs

EvaluationDrugModalityDoseRoute
Subject GLP-1(7-36) Unknown 0.2 unknown Intravenous
Subject GLP-1(7-36) Unknown 0.4 unknown Intravenous
Subject GLP-1(7-36) Unknown 0.8 unknown Intravenous